UroToday - Bladder Cancer

Home

Bladder Cancer

UroToday's Bladder Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of bladder cancer. Also available are conference coverage for all timely bladder cancer science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.

Display

results per page

Results 301 - 350 of 1748

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Identification of Urine PLK2 as a Marker of Bladder Tumors by Proteomic Analysis - Abstract
Thursday, 02 July 2009
Department of Urology, St. Joseph Hospital, Huwei, Yunlin, Taiwan.
read more

Quality of Pathologic Response and Surgery Correlate With Survival for Patients With Completely Resected Bladder Cancer After Neoadjuvant Chemotherapy - Abstract
Thursday, 02 July 2009
Department of Medicine, Section of Medical Oncology, Baylor College of Medicine, Houston, Texas.
read more

Photocure Submits Application for Marketing Approval for Hexvix® in USA to the FDA
Thursday, 02 July 2009
OSLO, NORWAY (Press Release) - June 30, 2009
read more

Neoadjuvant Versus Adjuvant Chemotherapy for Muscle-Invasive Bladder Cancer - Abstract
Wednesday, 01 July 2009
Vanderbilt University Medical Center, A-1302 Medical Center North, Nashville, TN 37232-2765, USA.
read more

Pelvic Lymphadenectomy During Radical Cystectomy: A Review of the Literature - Abstract
Wednesday, 01 July 2009
Urology Unit, Humanitas Gavazzeni Hospital, Via M. Gavazzeni 29, 24125 Bergamo, Italy.
read more

Time-Lapse Live Cell Imaging and Flow Analysis of Multidrug Resistance Reversal by Verapamil in Bladder Cancer Cell Lines - Abstract
Wednesday, 01 July 2009
Department of Urology, Southampton University Hospitals, National Health Service Trust, Southampton, United Kingdom.
read more

Characterization of Prostate Cancer Incidentally Detected in Radical Cystoprostatectomy Specimens from Japanese Men with Bladder Cancer - Abstract
Tuesday, 30 June 2009
Division of Urology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan.
read more

Novel Therapeutics for Patients With Non-Muscle-Invasive Bladder Cancer - Abstract
Tuesday, 30 June 2009
The University of Texas MD Anderson Cancer Center, Division of Urology, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.
read more

Definition and Management of Patients With Bladder Cancer Who Fail BCG Therapy - Abstract
Tuesday, 30 June 2009
Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
read more

Outcome of Recurrent and Metastatic Small Cell Carcinoma of the Bladder - Abstract
Tuesday, 30 June 2009
Department of Medical Oncology, National Institute of Oncology, Rabat, Morocco.
read more

Staging and Reporting of Urothelial Carcinoma of the Urinary Bladder - Abstract
Monday, 29 June 2009
Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, 350 West 11th Street, Clarian Pathology Laboratory Room 4010, Indianapolis, IN 46202, USA.
read more

Histological Variants of Urothelial Carcinoma: Diagnostic, Therapeutic and Prognostic Implications - Abstract
Monday, 29 June 2009
Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, 8700 BeverlyBlvd. Suite 8728, Los Angeles, California 90048, USA.
read more

Is Neoadjuvant Chemotherapy with Gemcitabine Plus Cisplatin Beneficial in Patients With Muscle-Invasive Bladder Cancer? - Abstract
Monday, 29 June 2009
Department of Surgery (Urology), McGill University, Montreal, Quebec, Canada.
read more

Beyond the Abstract - Outcomes of Patients Undergoing Radical Cystoprostatectomy for Bladder Cancer with Prostatic Involvement on Final Pathology
Friday, 26 June 2009
BERKELEY, CA (UroToday.com) - Urothelial carcinoma (UC) can invade the prostate in men with bladder cancer.
Login to read more...

XPD Polymorphisms, Cigarette Smoking, and Bladder Cancer Risk: A Meta-Analysis - Abstract
Friday, 26 June 2009
Departments of Molecular and Genetic Toxicology, Cancer Center of Nanjing Medical University, Nanjing, China.
read more

UHRF1 is a Novel Molecular Marker for Diagnosis and the Prognosis of Bladder Cancer - Abstract
Friday, 26 June 2009
Laboratory for Biomarker Development, The Institute of Physical and Chemical Research, RIKEN, Tokyo 108-8639, Japan.
read more

Diagnosis of Urothelial Carcinoma From Urine - Abstract
Friday, 26 June 2009
Department of Pathology, Centre Hospitalier Universitaire de Québec, L'Hôtel-Dieu de Québec, Laval University, 11, Côte du Palais, Québec, QC G1R 2J6, Canada.
read more

Orthotopic Ileal Neobladder Reconstruction in Patients with Recurring Bladder Cancer After Renal Transplantation - A Report of Two Cases and a Review of the Literature - Abstract
Thursday, 25 June 2009
The Division of Urology, Beijing Organ Transplantation Center, Beijing ChaoYang Hospital, Capital University of Medical Sciences, Beijing, China.
read more

The MRC Superficial Bladder Cancer Trial of Intravesical Mytomicin-c After Complete Surgical Resection. Sequential Statistical Methods Applied to Survival Data from a Randomised Clinical Trial - Abstract
Thursday, 25 June 2009
King's College London Dental Institute, Weston Education Centre, Office 262, Denmark Hill Campus, London SE5 9RJ, UK.
read more

CEACAM1: A Novel Urinary Marker for Bladder Cancer Detection - Abstract
Thursday, 25 June 2009
Department of Urology, University Hospital Grosshadern, Munich, Germany.
read more

Determinants of Quality of Interview and Impact on Risk Estimates in a Case-Control Study of Bladder Cancer - Abstract
Wednesday, 24 June 2009
The authors evaluated potential determinants of the quality of the interview in a case-control study of bladder cancer and assessed the effect of the interview quality on the risk estimates.
read more

Combination of BCG and Interferon Intravesical Immunotherapy: An Update - Abstract
Wednesday, 24 June 2009
Department of Urology, University of Iowa, 200 Hawkins Dr., 3 RCP, Iowa City, IA, 52242-1089, USA.
read more

Complications Following Radical Cystectomy for Bladder Cancer in the Elderly - Abstract
Wednesday, 24 June 2009
Department of Urology, University Hospital "Carl Gustav Carus", Technical University of Dresden, Dresden, Germany.
read more

The Current Role of Telomerase in the Diagnosis of Bladder Cancer - Abstract
Tuesday, 23 June 2009
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Via Piero Maroncelli 40, 47014 Meldola (FC), Italy.
read more

Inverted Urothelial Papilloma of the Urinary Bladder with Focal Papillary Pattern: A Previously Undescribed Feature - Abstract
Tuesday, 23 June 2009
Pathology Department, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubirán, Mexico City C.P. 14000, Mexico.
read more

FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder Cancer - Abstract
Tuesday, 23 June 2009
Department of Urology, AZ Groeninge, Kortrijk, Belgium.
read more

Second Opinion Pathology in Tertiary Care of Patients with Urologic Malignancies - Abstract
Tuesday, 23 June 2009
Division of Urology, Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL 62794, USA.
read more

Conservative Management of Upper Tract Transitional Cell Carcinoma - Abstract
Monday, 22 June 2009
Department of Urology, Mayo Clinic, Rochester, MN, USA.
read more

Bladder Carcinoma: MDCT Cystography and Virtual Cystoscopy - Abstract
Monday, 22 June 2009
Department of Radiological Sciences, University of Rome, Rome, Italy.
read more

Expression of Survivin and its Spliced Variants in Bladder Tumors as a Potential Prognostic Marker - Abstract
Monday, 22 June 2009
Department of Genetics, Faculty of Basic Sciences, Tarbiat Modarres University, Tehran, Iran.
read more

De Novo Cancers Arising in Organ Transplant Recipients are Associated with Adverse Outcomes Compared with the General Population - Abstract
Monday, 22 June 2009
Division of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0558, USA.
read more

Exploring Contrary Trends in Bladder Cancer Incidence, Mortality and Survival: Implications for Research and Cancer Control - Abstract
Friday, 19 June 2009
Epidemiology Branch, Department of Health, South Australia.
read more

Effect of Prophylactic Intravesical Instillation of BCG for Superficial Bladder Cancer - Abstract
Friday, 19 June 2009
Department of Urology, Osaka Medical College.
read more

Automobile Industry Occupations and Bladder Cancer: A Population-Based Case-Control Study in Southeastern Michigan, USA - Abstract
Friday, 19 June 2009
Department of Community and Preventive Medicine, University of Rochester Medical Center, United States.
read more

Outcome After Radical Cystectomy in Patients with Clinical T2 Bladder Cancer in Whom Neoadjuvant Chemotherapy has Failed - Abstract
Friday, 19 June 2009
Departments of Urology and Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA.
read more

Dose Distribution in Bladder and Surrounding Normal Tissues in Relation to Bladder Volume in Conformal Radiotherapy for Bladder Cancer - Abstract
Friday, 19 June 2009
Department of Radiotherapy, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland.
read more

Do Smoking and Polymorphisms in Xenobiotic Metabolizing Enzymes Affect the Histological Stage and Grade of Bladder Tumors? - Abstract
Friday, 19 June 2009
Laboratoire de génétique, d'immunologie et de pathologies humaines, faculté des sciences de Tunis El-Mannar-I, 2092 Tunis, Tunisie.
read more

Bladder Cancer, by Prof. Dr. Donald S. Kaufman MD, Prof. William U. Shipley MD, and Adam S. Feldman MD - Abstract
Friday, 19 June 2009
Department of Medicine, the Claire and John Bertucci Center for Genitourinary Cancers, Massachusetts General Hospital, Boston, MA, USA
read more

Imaging Appearance of Granulomatous Disease After Intravesical Bacille Calmette-Guerin (BCG) Treatment of Bladder Carcinoma - Abstract
Thursday, 18 June 2009
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10022, USA.
read more

MDCT Urography: Exploring a New Paradigm for Imaging of Bladder Cancer - Abstract
Thursday, 18 June 2009
Department of Radiology, University of Michigan Health System and University of Michigan Hospital, Ann Arbor, 48109-5030, USA.
read more

Fibroblast Growth Factor Receptor 1 Promotes Proliferation and Survival via Activation of the Mitogen-Activated Protein Kinase Pathway in Bladder Cancer - Abstract
Thursday, 18 June 2009
Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St. James's University Hospital, Leeds, United Kingdom.
read more

Brachytherapy Versus Cystectomy in Solitary Bladder Cancer: A Case Control, Multicentre, East-Netherlands Study - Abstract
Wednesday, 17 June 2009
Institute for Radiation Oncology Arnhem, The Netherlands.
read more

Small Cell Cancer of the Bladder: Pathology, Diagnosis, Treatment and Prognosis - Abstract
Wednesday, 17 June 2009
Department of medical oncology, national institute of oncology Sidi-Mohamed-Ben-Abdellah, avenue Allal-El-Fassi, 10000 Rabat, Maroc, Department of medical oncology, centre Léon-Bérard, 28, rue Laennec, Lyon-69008, France.
read more

Imaging and Staging of Transitional Cell Carcinoma: Part 2, Upper Urinary Tract - Abstract
Wednesday, 17 June 2009
Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030-4009, USA.
read more

Detection of Urothelial Bladder Cancer Cells in Voided Urine Can Be Improved by a Combination of Cytology and Standardized Microsatellite Analysis - Abstract
Tuesday, 16 June 2009
Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland.
read more

Treatment of Nonmuscle Invading Bladder Cancer: Do Physicians in the United States Practice Evidence Based Medicine?: The Use and Economic Implications of Intravesical Chemotherapy After Transurethral Resection of Bladder Tumors - Abstract
Tuesday, 16 June 2009
Department of Urology, University of Rochester School of Medicine, Rochester, New York.
read more

Determining Urinary Trace Elements (Cu, Zn, Pb, As, and Se) in Patients with Bladder Cancer - Abstract
Tuesday, 16 June 2009
Department of Biotechnology, Chia-Nan University of Pharmacy and Science, Tainan, Taiwan.
read more

Imaging and Staging of Transitional Cell Carcinoma: Part 1, Lower Urinary Tract - Abstract
Tuesday, 16 June 2009
Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030-4009, USA.
read more

Outcomes and Response to Therapy in Bladder Cancer. Are Biomarkers of Any Help? - Abstract
Monday, 15 June 2009
Department of Urology, University Clinic of Erlangen, Erlangen, Germany.
read more

Inter-Observer Variability of Clinical Target Volume Delineation for Bladder Cancer Using CT and Cone Beam CT - Abstract
Monday, 15 June 2009
Division of Radiation Oncology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria 3002, Australia.
read more

Focus on Bladder Cancer

Focus on Bladder Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Exclusive!
Interview with Barry Stein, MD on Clinical Practice Experience with NMP22

Podcast - San Francisco Firefighters and Bladder Cancer Screening

Synergistic potentiation of interferon activity with maitake mushroom D-fraction on bladder cancer cells

- by Sensuke Konno, PhD, et al.

Non-invasive methods to detect schistosome-based bladder cancer: is the association sufficient for epidemiological use?

- by Clive Shiff, MD and Robert W. Veltri, MD

Urinary Bladder Cancer: Diffusion-Weighted MR Imaging--Accuracy for Diagnosing T Stage and Estimating Histologic Grade

- by Mitsuru Takeuchi, MD

Clinical Outcome of Chemoradiotherapy for T1G3 Bladder Cancer

- by Masaharu Inoue, MD, et al.

External Beam Radiation Therapy Followed by Interstitial Radiotherapy with Iridium-192 for Solitary Bladder Tumours: Results of 111 Treated Patients

- by lze E.W. van Onna, MD

Bladder Tumor Markers: From Hematuria to Molecular Diagnostics - Where Do We Stand?

- by Samir Shirodkar, MD

Familial and Genetic Risk of Transitional Cell Carcinoma of the Urinary Tract

- by Christine M. Mueller, DO, et al.

Bladder-Sparing Therapy for Muscle-Infiltrating Bladder Cancer

- by Paolo Emiliozzi, MD

Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation?

- by Christopher P. Evans, MD, FACS

The Novel Use of Intravesical Docetaxel for the Treatment of Non-Muscle Invasive Bladder Cancer Refractory to BCG Therapy: A Single Institution Experience

- by David P. Wood, Jr. MD

Predictive Value of Telomerase Reverse Transcriptase Expression in Patients with High Risk Superficial Bladder Cancer Treated with Adjuvant BCG Immunotherapy

- by David P. Wood, Jr. MD

Prognostic Significance of Nondiagnostic Molecular Changes in Urine Detected by UroVysion Fluorescence In Situ Hybridization During Surveillance for Bladder Cancer

- by David P. Wood, Jr. MD

Cultured Milk, Yogurt, and Dairy Intake in Relation to Bladder Cancer Risk in a Prospective Study of Swedish Women and Men

- by David P. Wood, Jr. MD

Adjuvant Methotrexate, Vinblastine, Adriamycin, and Cisplatin Chemotherapy has Potential to Prevent Recurrence of Bladder Tumors After Surgical Removal of Upper Urinary Tract Transitional Cell Carcinoma

- by David P. Wood, Jr. MD

Matrix Metalloproteinase Polymorphisms Are Associated with Bladder Cancer Invasiveness

- by Ricardo Sånchez-Ortiz, MD - Editor's Pick

Laparoscopic Radical Cystectomy for Cancer: Oncological Outcomes at up to 5 years

- by David P. Wood, Jr. MD - Editor's Pick

Safety and Efficacy of Ofloxacin on Bacillus Calmette-Guerin Induced Toxicity in Patients with Superficial Bladder Cancer

- by Yassine Nouira, MD, et al.

Efficacy of Bacillus Calmette-Guerin (BCG) Therapy and Cauterization of the Tumor Versus BCG Therapy Without Cauterization for Superficial Bladder Cancer

- by Siavash Falahatkar, MD, et al.

A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

- by Louis S. Liou, MD, et al.

Utilization of the NMP22® BladderChek® Urine Test as an Adjunct to Atypical Cytology in the Detection of Bladder Cancer Recurrence

- by Ravi Munver, MD, et al.

Long Term Clinical Outcome of a Phase I Trial of Intravesical Docetaxel in the Management of Superficial Bladder Cancer Refractory to Standard Intravesical Therapy

- by Mitchell C. Benson, MD, and James M McKiernan, MD

Investigation of Publication Bias Using the Model of p53 Accumulation in Bladder Cancer

- by Peter J. Goebell, MD, et al.

Should All Patients Receive Single Chemotherapeutic Agent Instillation after Bladder Tumour Resection?

Therapeutic Options in the Management of Intermediate-Risk Nonmuscle-Invasive Bladder Cancer

Two Centuries of Cystoscopy: The Development of Imaging, Instrumentation and Synergistic Technologies

Bladder Cancer and the Aluminium Industry: A Review

Invasive T1 Bladder Cancer: Indications and Rationale for Radical Cystectomy

Bladder Cancer Screening

Improved Detection and Surveillance of Bladder Cancer Using a Point-of-Care NMP22 Assay

- by Mark S. Soloway, MD

Improving the Diagnosis of Bladder Cancer -Combining Cystoscopy with a Physician's Office Tumor Marker Test

- CME Training Program

Improved Detection of Bladder Cancer in Diagnosis and Surveillance Patients Using a Point-of-Care Proteomic Assay
- Barry Stein, MD on Improved Detection of Bladder Cancer in Diagnosis

Should We Screen for Bladder Cancer in a High Risk Population: A Cost per Life-Year Saved Analysis?
- Yair Lotan, MD on Screening for Bladder Cancer

Wisconsin Industrial Workers Might Be At Increased Risk For Bladder Cancer
- Giora Katz, MD Reports on Increased Risk for Bladder Cancer

Utility of NMP22 BladderCheck Point-Of-Care Assay In Evaluation Of Hematuria: A Multicenter Study
- Giora Katz, MD on the Utility of NMP22 Bladdercheck

Initial Diagnosis Of Bladder Cancer Using A Point-Of-Care Assay
- H. Barton Grossman, MD & the NMP22 Clinical Investigation Group

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of non-muscle invasive bladder cancer: Use of 2007 AUA guidelines
- Multimedia Lecture by Muhammad Choudhury, MD from the AUA NY Section 107th Annual Meeting

Improving survival for patients with bladder cancer
- Multimedia Lecture by Ralph de Vere White, MD from the AUA NY Section 107th Annual Meeting

Fluorescence cystoscopy for detection of initial and recurrent bladder cancer
- Multimedia Lecture by Ihor Sawczuk, MD from the AUA NY Section 107th Annual Meeting

Early cystectomy for T1 bladder cancer
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Treatment of muscle invasive bladder cancer in elderly
- Slide Presentation by David P. Wood, Jr., MD from the VI Maratona Urológica

Robotic extended pelvic lymphadenectomy for bladder cancer: Initial experience with greater nodal yield
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

Open versus robot-assisted radical cystectomy: Comparison of early outcomes and cost
- Session Highlight by Jason Lee, MD, FRCSC from the 2009 World Congress of Endourology

The impact of fibrin clot inhibitor medications on the efficacy of Bacillus Calmette-Guerin therapy for urothelial carcinoma of the bladder
- Presented by Stephen A. Boorjian, MD

American Society of Clinical Oncology (ASCO) 2009 Annual Meeting
- View Bladder Cancer Session Highlights
American Urological Association (AUA) 2009 Annual Meeting
- View Bladder Cancer Session Highlights from the AUA 2009 Annual Meeting
10 Tips for Non-Muscle Invasive Bladder Cancer
- Lecture presented at WUF 2009 by David P. Wood, Jr., MD

Society of Urologic Oncology (SUO) 9th Annual Winter Meeting
- View Bladder Cancer Session Highlights

Robot Assisted Radical Cystectomy: Is it Ready for Prime Time?
- Session Highlight from AUA Western Section 2008

Bladder Cancer Cytology and Markers in Diagnosis and Assessment
- Presentation from the 2008 AUA NY Meeting

Re-Staging Transurethral Resection: Who Benefits?
- Slide Presentation from the 2008 AUA NY Section Meeting

Non-Muscle Invasive Transitional Cell Carcinoma
- Slide Presentation from the 2008 Masters in Urology Conference
American Society of Clinical Oncology 44th Annual Meeting
- Bladder Cancer Abstracts

The American Urological Association 2008 Annual Meeting
- Bladder Cancer Session Highlights

Engineering and Urology Society 23rd Annual Meeting
- Bladder Cancer Abstracts